Skip to content

Medical emergency? What to do

Co-pays, drug cuts to save Medicaid $11 bln:report

3-RXPublished September 3, 20053 min read

Key points

  • A federal commission on Thursday recommended $11 billion in Medicaid savings over 5 years from raising prescription drug co-payments, drug pricing reforms and curbs against asset transfers to qualify for benefits.
  • Costs for the state-federal health care program for the poor have grown dramatically in recent years, reaching $329 billion in the fiscal year ended June 30, according to the National Governors' Association.
  • The panel's efforts have been sharply criticized by congressional Democrats as being one-sided because only members appointed by President George W.
  • The commission, co-chaired by former Tennessee Gov.

A federal commission on Thursday recommended $11 billion in Medicaid savings over 5 years from raising prescription drug co-payments, drug pricing reforms and curbs against asset transfers to qualify for benefits.

The controversial Medicaid Commission, charged in May with finding $10 billion in immediate savings, delivered its first of two reports to Congress and Health and Human Services Secretary Michael Leavitt.

Costs for the state-federal health care program for the poor have grown dramatically in recent years, reaching $329 billion in the fiscal year ended June 30, according to the National Governors' Association.

It provides care to more than 53 million Americans, but some states, including Tennessee and Missouri, have cut benefits due to cope with growing costs.

The panel's efforts have been sharply criticized by congressional Democrats as being one-sided because only members appointed by President George W. Bush were allowed to vote.

The most controversial suggestion is to allow states flexibility to increase co-payments beyond nominal amounts in certain cases to encourage use of more cost-effective drugs.

The commission, co-chaired by former Tennessee Gov. Don Sundquist and former Maine Gov. Angus King, said this move would save $2 billion over the five-year period.

Currently, drug co-payments are capped at $3 and are prohibited for some patients and services. The commission's report said co-payments should remain nominal for people at or below the federal poverty line and for "preferred" drugs.

Some public health advocates have criticized co-payment proposals, saying they would cost more in the long run because many beneficiaries cannot afford even nominal co-payments. Rather than pay, they will put off treatment or turn to hospital emergency rooms for uncompensated care.

"It's an illusory cost-shift," said Dr. Georges Benjamin, executive director of the American Public Health Association. "These people just don't have the money."

TEPID RECEPTION

The suggestions received a tepid reception from Senate Finance Committee Chairman Chuck Grassley, an Iowa Republican, who said they would be considered in budget reconciliation talks to meet a September 16 deadline.

"It's premature to discuss the likelihood that any one option will be included in the Finance Committee package," he said in a statement.

The commission said $4.3 billion could be saved if states were allowed to establish drug reimbursement prices based on average manufacturer prices rather than the current method of using average wholesale prices, which are typically higher than prices actually paid by pharmacies.

Another $2 billion would be saved by allowing states to collect drug manufacturer rebates on behalf of Medicaid managed care health plans. Currently federal laws prohibit this, which means they are missing out on average rebates of 15.1 percent of average manufacturer prices for brand name drugs and 11 percent for generic drugs.

The commission also recommended rule changes to prevent patients from improperly transferring assets in order to qualify for Medicaid nursing home care benefits, which would save $1.5 billion, and closing tax loopholes for managed care organizations, which would save $1.2 billion.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDrug News

Keep reading

Cancer

Experimental drug shrinks cancer tumors

An experimental cancer drug successfully shrank tumors in patients with different kinds of cancer, including typically hard-to-treat lung cancers, according to a new study. Oncologists said the research was…

4 min read

Cancer

Avastin Slows Resistant Ovarian Cancer

Progression of platinum-resistant ovarian cancer slowed by more than 50% in patients who received bevacizumab (Avastin) plus chemotherapy compared with nonplatinum chemotherapy alone, results of a randomized trial…

3 min read

Drug News

Prevnar trial results needed for CDC recommendation

Advisors to the U.S. Centers for Disease Control and Prevention on Wednesday will wait for results from a trial of Pfizer Inc's Prevnar 13 pneumonia vaccine before deciding whether to recommend its use in all adults…

1 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.